From the Research
Role of Stellate Ganglion Block in Lymphedema Management
- The stellate ganglion block (SGB) has been proposed as a treatment option for lymphedema, with studies suggesting its potential in improving lymphedema symptoms 1, 2.
- A systematic review of publications on the use of SGB in lymphedema treatment found that SGB promoted lymphedema improvement, expressed by decreased limb circumference and patient-reported outcomes 1.
- A case report demonstrated the benefits of SGB for intractable upper limb lymphedema, with patients experiencing decreased swelling and pain after treatment 2.
- Another study found that SGB can be considered for improving perfusion in limbs, which may be beneficial for lymphedema patients 3.
- The exact mechanism of SGB in alleviating lymphedema is not fully understood, but it is thought to modulate the immune system activity and lead to the alleviation of the disease 4.
- A literature review suggested that SGB may have beneficial effects on the management of breast cancer-related lymphedema, although further studies are required to prove its efficacy 5.
Key Findings
- SGB has been shown to improve lymphedema symptoms, including decreased limb circumference and patient-reported outcomes.
- The treatment is thought to modulate the immune system activity, leading to the alleviation of the disease.
- Further studies are required to fully understand the mechanism of SGB in lymphedema management and to prove its efficacy.
Potential Benefits
- Improved lymphedema symptoms, including decreased swelling and pain.
- Potential for improved perfusion in limbs.
- May be beneficial for breast cancer-related lymphedema.
- May modulate the immune system activity, leading to the alleviation of the disease.